Whistle-Blower of Unsafe Medicines Takes on `Made in India'

The man who helped U.S. prosecutors reach the largest safety settlement ever with a generic-drug company is now trying to take on the entire pharmaceuticals industry in India, which he alleges makes unsafe medicines and sells them worldwide.

Dinesh Thakur, the whistle-blower who helped the U.S. government show systemic product-testing failures at Ranbaxy that led to the $500 million settlement in 2013, says poor-quality manufacturing is a problem at many more companies in India, the second largest supplier of over-the-counter and prescription drugs in the U.S. Frustrated by a fractured oversight system and the lack of progress even after the Ranbaxy case, Thakur is now suing the Indian government to force an overhaul of the industry’s regulation.